The molecular basis of prostate cancer

A Yvonne Olsson(Institute of Cancer Research), Colin S. Cooper(Institute of Cancer Research)
British Journal of Hospital Medicine
November 1, 2005
10.12968/hmed.2005.66.11.20021
Cited by 4

Abstract

Cancer involves accumulation of genetic alterations. This review highlights the alterations in control pathways for cell division, development, DNA repair, angiogenesis and cell death that are believed to be key players in the development of prostate cancer.

Related Papers

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al.|Nature|2005|6.7k
Cancer genes and the pathways they control
Bert Vogelstein, Kenneth W. Kinzler|Nature Medicine|2004|4.3k
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al.|Nature|2002|2.7k
Molecular determinants of resistance to antiandrogen therapy
Charlie D. Chen, Derek S. Welsbie, Chris Tran et al.|Nature Medicine|2003|2.3k
To cycle or not to cycle: a critical decision in cancer
Marcos Malumbres, Mariano Barbacid|Nature reviews. Cancer|2001|1.5k